Key references: Initial pharmacotherapy for social anxiety disorder in adults and young people

  • Baldwin DS, Anderson IM, Nutt DJ, Allgulander C, Bandelow B, den Boer JA, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol 2014;28(5):403–39. https://www.ncbi.nlm.nih.gov/pubmed/24713617
  • Baldwin DS, Asakura S, Koyama T, Hayano T, Hagino A, Reines E, et al. Efficacy of escitalopram in the treatment of social anxiety disorder: A meta-analysis versus placebo. Eur Neuropsychopharmacol 2016;26(6):1062–9. https://www.ncbi.nlm.nih.gov/pubmed/26971233
  • Bandelow B, Reitt M, Rover C, Michaelis S, Gorlich Y, Wedekind D. Efficacy of treatments for anxiety disorders: a meta-analysis. Int Clin Psychopharmacol 2015;30(4):183–92. https://www.ncbi.nlm.nih.gov/pubmed/25932596
  • Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry 2014;14 Suppl 1:S1. https://www.ncbi.nlm.nih.gov/pubmed/25081580
  • Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, et al. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 2015;351:h4320. https://www.ncbi.nlm.nih.gov/pubmed/26376805
  • Liu X, Li X, Zhang C, Sun M, Sun Z, Xu Y, et al. Efficacy and tolerability of fluvoxamine in adults with social anxiety disorder: A meta-analysis. Medicine (Baltimore) 2018;97(28):e11547. https://www.ncbi.nlm.nih.gov/pubmed/29995828
  • Pelissolo A, Moukheiber A. Open-label treatment with escitalopram in patients with social anxiety disorder and fear of blushing. J Clin Psychopharmacol 2013;33(5):695–8. https://www.ncbi.nlm.nih.gov/pubmed/23948787
  • Robinson HM, Hood SD. Social anxiety disorder - a review of pharmacological treatments. Current Psychiatry Reviews 2007;3:95–122.